Exchange: OTC·Updated 02:45 PM EDT

BTAX Immune Therapeutics Inc

$0.0002
$0.0001
(100.00%)
Today
Mkt Cap$15,743.00
Vol278.00

About BTAX

Biostax Corp. engages in the acquisition, development, and commercialization of pharmaceutical and biotechnology products. Its partnered programs include JKB-122, Londonal, and Low Dose Naltrexone. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.
50

Neutral Sentiment

How do you feel about BTAX?

Advertisement|Remove ads.